GeneDx Holdings Corp. provided earnings guidance for the full year of 2024. For the year, the company expects revenues to be between $220 million and $230 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.74 USD | -3.61% | +8.02% | +908.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+908.73% | 725M | |
+68.25% | 4.32B | |
+5.45% | 2.74B | |
-2.80% | 2.62B | |
-51.24% | 1.95B | |
-19.04% | 1.67B | |
-22.51% | 1.41B | |
+16.69% | 1.2B | |
-44.81% | 1.12B | |
+17.51% | 975M |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- GeneDx Holdings Corp. Provides Earnings Guidance for the Full Year of 2024